Kraig Biocraft Laboratories deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a spring scale‑up effort that could eventually produce around 10 metric tons of recombinant spider‑silk cocoons per month.
The target of 10 metric tons per month represents a significant leap in production capacity, positioning the company to meet the growing demand for high‑strength, biodegradable fibers in performance apparel, technical textiles, and ballistic‑protection markets.
Initial shipments of the recombinant spider‑silk material are being prepared for several unnamed global brands as part of pilot development programs and first commercial deliveries, marking the first tangible move toward generating revenue after reporting zero revenue through Q3 2025.
The shift from laboratory research to commercial‑scale production signals a critical transition for KBLB, as the company has historically operated at a loss and has yet to achieve commercial sales. The deployment and upcoming deliveries provide the first evidence that the technology can be scaled and monetized.
Investor attention has intensified following the company’s National Geographic cover story in March 2026, which highlighted the cost‑efficiency and quality of the silkworm‑based production process. Brand engagement and pilot programs are expected to validate market demand and accelerate revenue generation.
CEO Kim Thompson said, "This is a transformative moment for Kraig Biocraft Laboratories… Establishing operations in Lam Dong has been a priority for more than ten years and now, with our footprint firmly in place, we are making significant investments to drive our production to unprecedented levels."
The deployment and initial commercial shipments position KBLB to capture a share of the emerging spider‑silk market, potentially transforming its revenue profile and competitive standing in high‑performance fiber applications.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.